Overall, these data show a stability of the DNMT3A mutations in AML engrafted mice and suggest a preferential engraftment of primary AML specimens with triple FLT3-ITD/NPM1/DNMT3A mutations in immunodeficient mice. The gene discussed is FLT3; the disease is acute myeloid leukemia.